1-4 of 4
Gaurav Gupta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Despite High Rates of Remission, Treatment of IDH-Mutant AML with Hypomethylating Agents and Venetoclax Is Associated with Frequent Treatment Delays, Modifications, and Transfusions

Kuo-Kai Chin, Andriy Derkach, Christopher Famulare, Gaurav Gupta, Prabhakar Borge, Ellin Berman, Mark Blaine Geyer, Aaron D. Goldberg, Tamanna Haque, Raajit K. Rampal, Jae H. Park, Lindsey E. Roeker, Martin S. Tallman, Eytan M. Stein
Journal: Blood
Blood (2023) 142 (Supplement 1): 1519.
https://doi.org/10.1182/blood-2023-182012
Published: 2023
Journal Articles

Stem Cell Utilization in the Era of Novel Therapies for Multiple Myeloma

Noriko Nishimura, David Nemirovsky, Sean M. Devlin, Parastoo B. Dahi, Heather Landau, Oscar Boutros Lahoud, Michael Scordo, Gunjan L. Shah, Sham Mailankody, Hani Hassoun, Kylee H Maclachlan, Malin Hultcrantz, Neha Korde, Alexander Lesokhin, Urvi A Shah, Carlyn Tan, Gaurav Gupta, Elena Maryamchik, Rugved Pattarkine, Grace Linder, Saad Z Usmani, Sergio A. Giralt, David Chung
Journal: Blood
Blood (2023) 142 (Supplement 1): 2219.
https://doi.org/10.1182/blood-2023-188103
Published: 2023
Journal Articles

Stem Cell Autograft Minimal Residual Disease Negativity Improves Outcomes after Autotransplant for Multiple Myeloma

Noriko Nishimura, Samantha Brown, Sean M. Devlin, Parastoo B. Dahi, Heather Landau, Oscar B Lahoud, Michael Scordo, Gunjan L. Shah, Hani Hassoun, Malin Hultcrantz, Neha Korde, Alexander M Lesokhin, Sham Mailankody, Urvi A Shah, Carlyn Tan, Saad Usmani, Sergio A. Giralt, David J. Chung, Gaurav Gupta, Elena Maryamchik, Evangelos Ntrivalas, Mikhail Roshal
Journal: Blood
Blood (2022) 140 (Supplement 1): 620–622.
https://doi.org/10.1182/blood-2022-160271
Published: 2022
Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): Pathologic Classification and Clinical Outcomes from a Multicenter Consensus Study

Andrew M Evens, DO, MSc, FACP, Monika Pilichowska, MD, Stefania Pittaluga, MD PhD, Judith Ferry, MD, Jessica Hemminger, MD, Jennifer A. Kanakry, Laurie H. Sehn, Tatyana Feldman, MD, Jeremy S. Abramson, MD, Francisco J. Hernandez-Ilizaliturri, MD, Izidore S Lossos, MD, Oliver W Press, MD PhD, Timothy S. Fenske, MD, Jonathan Friedberg, MD, Julie M Vose, MD, Kristie A. Blum, MD, Deepa Jagadeesh, Gaurav Gupta, MD PhD, Randy D Gascoyne, MD, Elaine Jaffe, MD
Journal: Blood
Blood (2016) 128 (22): 4145.
https://doi.org/10.1182/blood.V128.22.4145.4145
Published: 2016